Apheresis Equipment Market Size, Trends and Insights By Product Type (Plasmapheresis Equipment, Photopheresis Equipment, LDL Apheresis Equipment, Others), By Technology (Centrifugation Apheresis, Membrane Filtration Apheresis), By Application (Renal Disease, Neurology, Hematology, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Blood Donation Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Reports Description
As per the current market research conducted by the CMI Team, the global Apheresis Equipment Market is expected to record a CAGR of 12.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4,673.2 Million. By 2033, the valuation is anticipated to reach USD 13,169.1 Million.
The apheresis equipment market comprises devices used to separate specific blood components for therapeutic purposes. These devices are critical in treating various medical conditions such as autoimmune disorders, neurological diseases, and haematological malignancies.
Apheresis procedures involve extracting blood from patients, separating the targeted component (plasma, platelets, or white blood cells) using centrifugation or membrane filtration, and returning the remaining blood components to the patient.
The market is driven by technological advancements, expanding applications across different medical specialties, and increasing demand for specific blood components for transfusion and therapeutic purposes, supported by growing healthcare infrastructure globally.
Apheresis Equipment Market – Significant Growth Factors
The Apheresis Equipment Market presents significant growth opportunities due to several factors:
- Rising Prevalence of Chronic Diseases: The increasing incidence of autoimmune disorders, haematological diseases, and neurological conditions necessitates therapeutic apheresis, driving the market growth.
- Technological Advancements: Continuous innovations in apheresis equipment, such as enhanced automation and improved safety features, are improving treatment outcomes and expanding the market.
- Growing Demand for Blood Components: Hospitals and blood centers require apheresis equipment to meet the rising demand for specific blood components like plasma and platelets, driven by increasing transfusion needs.
- Expanding Applications in Medical Treatments: Apheresis is increasingly utilized in treating a broader spectrum of medical conditions, including metabolic disorders and oncology, further boosting market demand.
- Emerging Markets Expansion: Opportunity exists in expanding into emerging markets where healthcare infrastructure is improving, and there is rising awareness and adoption of advanced medical treatments like apheresis.
- Personalized Medicine and Precision Therapies: Apheresis equipment can play a crucial role in personalized medicine by facilitating targeted therapies and precision medicine approaches, presenting a significant opportunity for market growth and innovation.
- Integration with Digital Health Technologies: There is an opportunity to integrate apheresis equipment with digital health technologies such as telemedicine platforms and remote monitoring devices. This integration can enhance patient management, optimize treatment protocols, and improve operational efficiencies, thereby driving adoption and market expansion in the era of digital healthcare solutions.
Apheresis Equipment Market – Mergers and Acquisitions
The Apheresis Equipment Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Apheresis Equipment Market include:
- In 2023, Terumo Corporation introduced a pioneering training program aimed at enhancing cell and gene therapy manufacturers’ cell collection processes. This initiative in the apheresis market aims to equip participants with advanced skills to expedite therapeutic commercialization and improve treatment outcomes.
- In 2023, Fresenius Kabi AG and Lupagen Inc. entered a supply and development agreement focused on technologies designed to advance the delivery of cell and gene therapies directly to patients’ bedsides. This collaboration aims to enhance therapeutic accessibility and efficacy.
- In 2023, TERUMO BCT, INC. received FDA clearance for a platelet device that processes blood into platelets using a single centrifugation cycle. This innovation promises efficiency in platelet production, potentially improving patient care and medical outcomes.
These mergers and acquisitions helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Apheresis Equipment Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Apheresis Equipment Market | Medical Aesthetics Market | Genetic Engineering Market |
| CAGR 12.2% (Approx) | CAGR 8.4% (Approx) | CAGR 6.74% (Approx) |
| USD 13,169.1 Million by 2033 | USD 36,168.8 Million by 2033 | USD 2,917.2 Million by 2033 |
Apheresis Equipment Market – Significant Threats
The Apheresis Equipment Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
- Stringent Regulatory Requirements: Complex regulatory pathways for approval of apheresis devices can delay market entry and increase development costs, posing a barrier to new entrants and innovation.
- High Cost of Equipment and Procedures: The substantial initial investment required for apheresis equipment, coupled with the high cost of procedures, may limit adoption and accessibility, especially in resource-constrained healthcare settings.
- Competition and Pricing Pressures: Intense competition among key players and the presence of alternative therapies can lead to price wars and margin pressures, impacting profitability and market stability.
- Technological Risks and Device Failures: Risks associated with technological malfunctions, device failures, or adverse events during procedures can undermine patient confidence and prompt regulatory scrutiny, damaging market reputation.
- Economic Uncertainty and Healthcare Budget Constraints: Economic downturns and healthcare budget constraints can reduce healthcare spending and delay investments in new apheresis equipment, affecting market growth and adoption rates.
Category-Wise Insights
By Product Type:
- Plasmapheresis Equipment: Plasmapheresis equipment separates plasma from blood components for therapeutic use in conditions like autoimmune disorders and plasma exchange therapies. Trends include advancements in automated systems and disposable kits, enhancing efficiency and reducing procedural times.
- Photopheresis Equipment: Photopheresis equipment is used for extracorporeal photopheresis treatments, crucial in managing immune-mediated diseases like graft-versus-host disease (GVHD). Trends focus on improved device ergonomics and integration with digital monitoring for enhanced patient outcomes.
- LDL Apheresis Equipment: LDL apheresis equipment selectively removes low-density lipoprotein (LDL) cholesterol from the blood, aiding in managing hyperlipidemia and reducing cardiovascular risk. Trends include compact and portable systems, promoting outpatient use and patient convenience.
- Others: Other apheresis equipment includes systems for specific blood components like platelets or white blood cells, catering to diverse therapeutic needs. Trends involve customization for rare diseases and integration with personalized medicine approaches, driving innovation and expanding treatment options.
By Technology
- Centrifugation Apheresis: Centrifugation apheresis utilizes centrifugal force to separate blood components based on their density. This technology is pivotal in extracting plasma, platelets, or white blood cells for therapeutic purposes. Recent trends include advancements in centrifuge design for improved efficiency and automation, enhancing treatment precision and patient outcomes. Centrifugation remains a cornerstone in apheresis procedures due to its robustness and versatility in clinical applications.
- Membrane Filtration Apheresis: Membrane filtration apheresis employs semi-permeable membranes to selectively remove targeted blood components. This technology is integral in treating autoimmune diseases and removing low-density lipoprotein (LDL) cholesterol. Trends involve innovations in membrane materials to enhance biocompatibility and efficiency, enabling precise separation of blood constituents while minimizing side effects. Membrane filtration continues to evolve with advancements in membrane technology and device miniaturization, catering to diverse therapeutic needs.
By Application
- Renal Disease: Apheresis equipment in renal disease involves removing harmful substances from the blood, such as autoantibodies in autoimmune nephritis. Trends include advancements in membrane filtration technology for efficient toxin removal and the growing adoption of therapeutic plasma exchange (TPE) in managing kidney-related complications.
- Neurology: In neurology, apheresis treats disorders like Guillain-Barré syndrome by removing pathogenic antibodies. Trends include increased utilization of immunoadsorption techniques and the development of targeted therapies for neurological conditions.
- Haematology: Apheresis in Hematology focuses on extracting specific blood components like stem cells for transplantation in haematological malignancies. Trends include advancements in cell separation technology and the expansion of applications to include treating disorders like sickle cell disease.
- Others: Other applications encompass various medical conditions treated with apheresis, such as cardiovascular diseases and metabolic disorders. Trends involve expanding the scope of apheresis applications through personalized medicine approaches and the integration of digital health technologies for enhanced patient management.
By End Users
- Hospitals: Hospitals are major users of apheresis equipment, employing it for treatments across various specialties. Trends include increasing adoption of automated systems for efficiency and expanding applications in oncology and neurology.
- Ambulatory Surgical Centers (ASCs): ASCs utilize apheresis equipment for outpatient procedures, focusing on efficiency and patient comfort. Trends include growth in outpatient treatments and the adoption of portable and compact apheresis systems.
- Blood Donation Centers: Blood donation centers use apheresis equipment to collect specific blood components like platelets and plasma. Trends include advancements in collection technologies and increasing demand for specific blood products.
- Others: Other healthcare facilities, such as specialty clinics and research institutions, integrate apheresis equipment for specialized treatments and studies. Trends include collaborations for research advancements and expanding clinical applications beyond traditional uses.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 4,673.2 Million |
| Projected Market Size in 2033 | USD 13,169.1 Million |
| Market Size in 2023 | USD 4,165.1 Million |
| CAGR Growth Rate | 12.2% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product Type, Technology, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Apheresis Equipment Market – Regional Analysis
The Apheresis Equipment Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
- North America: North America leads in apheresis equipment adoption due to advanced healthcare infrastructure and high disease prevalence. Trends include an increasing focus on personalized medicine, technological innovations in automated systems, and a growing shift towards outpatient treatments in ASCs.
- Europe: Europe shows steady growth with expanding applications in autoimmune disorders and haematology. Trends include stringent regulatory standards, rising investments in healthcare technology, and collaborations for clinical research and the development of novel therapies.
- Asia-Pacific: Asia-Pacific exhibits rapid market expansion driven by improving healthcare access and rising chronic disease burden. Trends include growing healthcare expenditure, adoption of cost-effective apheresis technologies, and partnerships for local manufacturing and distribution to enhance accessibility.
- LAMEA (Latin America, Middle East, and Africa): The LAMEA region is experiencing increasing adoption of apheresis equipment amidst developing healthcare infrastructure. Trends include rising awareness about therapeutic benefits, government initiatives to enhance healthcare access, and partnerships for technology transfer and training to support market growth.
Competitive Landscape – Apheresis Equipment Market
The Apheresis Equipment Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:
- Terumo BCT Inc.
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Asahi Kasei Medical Co. Ltd.
- Baxter International Inc.
- Kaneka Corporation
- Braun Melsungen AG
- Nikkiso Co. Ltd.
- Medica S.p.A.
- Miltenyi Biotec
- Thermo Fisher Scientific Inc.
- Hemonetics Corporation
- Cerus Corporation
- MacoPharma
- Gambro
- Others
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
Emerging companies like Miltenyi Biotec and MacoPharma are leveraging innovation in apheresis equipment, focusing on advanced technologies such as automated systems and improved device integration for personalized therapies. These newcomers are expanding market horizons with novel approaches to meet evolving healthcare demands.
Established leaders such as Terumo BCT, Fresenius SE & Co. KGaA, and Haemonetics Corporation dominate the apheresis equipment market. They lead through extensive R&D investments, comprehensive product portfolios covering diverse therapeutic applications, and robust global distribution networks. These companies’ strategic acquisitions and partnerships bolster their market presence and sustain their leadership positions in the competitive landscape.
The Apheresis Equipment Market is segmented as follows:
By Product Type
- Plasmapheresis Equipment
- Photopheresis Equipment
- LDL Apheresis Equipment
- Others
By Technology
- Centrifugation Apheresis
- Membrane Filtration Apheresis
By Application
- Renal Disease
- Neurology
- Hematology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Blood Donation Centers
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Apheresis Equipment Market, (2024 – 2033) (USD Million)
- 2.2 Global Apheresis Equipment Market: snapshot
- Chapter 3. Global Apheresis Equipment Market – Industry Analysis
- 3.1 Apheresis Equipment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising Prevalence of Chronic Diseases
- 3.2.2 Technological Advancements
- 3.2.3 Growing Demand for Blood Components
- 3.2.4 Expanding Applications in Medical Treatments
- 3.2.5 Emerging Markets Expansion
- 3.2.6 Personalized Medicine and Precision Therapies
- 3.2.7 Integration with Digital Health Technologies.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End User
- Chapter 4. Global Apheresis Equipment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Apheresis Equipment Market: company market share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Apheresis Equipment Market – Product Type Analysis
- 5.1 Global Apheresis Equipment Market Overview: By Product Type
- 5.1.1 Global Apheresis Equipment Market Share, By Product Type, 2023 and 2033
- 5.2 Plasmapheresis Equipment
- 5.2.1 Global Apheresis Equipment Market by Plasmapheresis Equipment, 2024 – 2033 (USD Million)
- 5.3 Photopheresis Equipment
- 5.3.1 Global Apheresis Equipment Market by Photopheresis Equipment, 2024 – 2033 (USD Million)
- 5.4 LDL Apheresis Equipment
- 5.4.1 Global Apheresis Equipment Market by LDL Apheresis Equipment, 2024 – 2033 (USD Million)
- 5.5 Others
- 5.5.1 Global Apheresis Equipment Market by Others, 2024 – 2033 (USD Million)
- 5.1 Global Apheresis Equipment Market Overview: By Product Type
- Chapter 6. Global Apheresis Equipment Market – Technology Analysis
- 6.1 Global Apheresis Equipment Market Overview: By Technology
- 6.1.1 Global Apheresis Equipment Market Share, By Technology, 2023 and 2033
- 6.2 Centrifugation Apheresis
- 6.2.1 Global Apheresis Equipment Market by Centrifugation Apheresis, 2024 – 2033 (USD Million)
- 6.3 Membrane Filtration Apheresis
- 6.3.1 Global Apheresis Equipment Market by Membrane Filtration Apheresis, 2024 – 2033 (USD Million)
- 6.1 Global Apheresis Equipment Market Overview: By Technology
- Chapter 7. Global Apheresis Equipment Market – Application Analysis
- 7.1 Global Apheresis Equipment Market Overview: By Application
- 7.1.1 Global Apheresis Equipment Market Share, By Application, 2023 and 2033
- 7.2 Renal Disease
- 7.2.1 Global Apheresis Equipment Market by Renal Disease, 2024 – 2033 (USD Million)
- 7.3 Neurology
- 7.3.1 Global Apheresis Equipment Market by Neurology, 2024 – 2033 (USD Million)
- 7.4 Hematology
- 7.4.1 Global Apheresis Equipment Market by Hematology, 2024 – 2033 (USD Million)
- 7.5 Others
- 7.5.1 Global Apheresis Equipment Market by Others, 2024 – 2033 (USD Million)
- 7.1 Global Apheresis Equipment Market Overview: By Application
- Chapter 8. Global Apheresis Equipment Market – End User Analysis
- 8.1 Global Apheresis Equipment Market Overview: By End User
- 8.1.1 Global Apheresis Equipment Market Share, By End User, 2023 and 2033
- 8.2 Hospitals
- 8.2.1 Global Apheresis Equipment Market by Hospitals, 2024 – 2033 (USD Million)
- 8.3 Ambulatory Surgical Centers (ASCs)
- 8.3.1 Global Apheresis Equipment Market by Ambulatory Surgical Centers (ASCs), 2024 – 2033 (USD Million)
- 8.4 Blood Donation Centers
- 8.4.1 Global Apheresis Equipment Market by Blood Donation Centers, 2024 – 2033 (USD Million)
- 8.5 Others
- 8.5.1 Global Apheresis Equipment Market by Others, 2024 – 2033 (USD Million)
- 8.1 Global Apheresis Equipment Market Overview: By End User
- Chapter 9. Apheresis Equipment Market – Regional Analysis
- 9.1 Global Apheresis Equipment Market Regional Overview
- 9.2 Global Apheresis Equipment Market Share, by Region, 2023 & 2033 (USD Million)
- 9.3. North America
- 9.3.1 North America Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.3.1.1 North America Apheresis Equipment Market, by Country, 2024 – 2033 (USD Million)
- 9.3.1 North America Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.4 North America Apheresis Equipment Market, by Product Type, 2024 – 2033
- 9.4.1 North America Apheresis Equipment Market, by Product Type, 2024 – 2033 (USD Million)
- 9.5 North America Apheresis Equipment Market, by Technology, 2024 – 2033
- 9.5.1 North America Apheresis Equipment Market, by Technology, 2024 – 2033 (USD Million)
- 9.6 North America Apheresis Equipment Market, by Application, 2024 – 2033
- 9.6.1 North America Apheresis Equipment Market, by Application, 2024 – 2033 (USD Million)
- 9.7 North America Apheresis Equipment Market, by End User, 2024 – 2033
- 9.7.1 North America Apheresis Equipment Market, by End User, 2024 – 2033 (USD Million)
- 9.8. Europe
- 9.8.1 Europe Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.8.1.1 Europe Apheresis Equipment Market, by Country, 2024 – 2033 (USD Million)
- 9.8.1 Europe Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.9 Europe Apheresis Equipment Market, by Product Type, 2024 – 2033
- 9.9.1 Europe Apheresis Equipment Market, by Product Type, 2024 – 2033 (USD Million)
- 9.10 Europe Apheresis Equipment Market, by Technology, 2024 – 2033
- 9.10.1 Europe Apheresis Equipment Market, by Technology, 2024 – 2033 (USD Million)
- 9.11 Europe Apheresis Equipment Market, by Application, 2024 – 2033
- 9.11.1 Europe Apheresis Equipment Market, by Application, 2024 – 2033 (USD Million)
- 9.12 Europe Apheresis Equipment Market, by End User, 2024 – 2033
- 9.12.1 Europe Apheresis Equipment Market, by End User, 2024 – 2033 (USD Million)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.13.1.1 Asia Pacific Apheresis Equipment Market, by Country, 2024 – 2033 (USD Million)
- 9.13.1 Asia Pacific Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.14 Asia Pacific Apheresis Equipment Market, by Product Type, 2024 – 2033
- 9.14.1 Asia Pacific Apheresis Equipment Market, by Product Type, 2024 – 2033 (USD Million)
- 9.15 Asia Pacific Apheresis Equipment Market, by Technology, 2024 – 2033
- 9.15.1 Asia Pacific Apheresis Equipment Market, by Technology, 2024 – 2033 (USD Million)
- 9.16 Asia Pacific Apheresis Equipment Market, by Application, 2024 – 2033
- 9.16.1 Asia Pacific Apheresis Equipment Market, by Application, 2024 – 2033 (USD Million)
- 9.17 Asia Pacific Apheresis Equipment Market, by End User, 2024 – 2033
- 9.17.1 Asia Pacific Apheresis Equipment Market, by End User, 2024 – 2033 (USD Million)
- 9.18. Latin America
- 9.18.1 Latin America Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.18.1.1 Latin America Apheresis Equipment Market, by Country, 2024 – 2033 (USD Million)
- 9.18.1 Latin America Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.19 Latin America Apheresis Equipment Market, by Product Type, 2024 – 2033
- 9.19.1 Latin America Apheresis Equipment Market, by Product Type, 2024 – 2033 (USD Million)
- 9.20 Latin America Apheresis Equipment Market, by Technology, 2024 – 2033
- 9.20.1 Latin America Apheresis Equipment Market, by Technology, 2024 – 2033 (USD Million)
- 9.21 Latin America Apheresis Equipment Market, by Application, 2024 – 2033
- 9.21.1 Latin America Apheresis Equipment Market, by Application, 2024 – 2033 (USD Million)
- 9.22 Latin America Apheresis Equipment Market, by End User, 2024 – 2033
- 9.22.1 Latin America Apheresis Equipment Market, by End User, 2024 – 2033 (USD Million)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.23.1.1 The Middle-East and Africa Apheresis Equipment Market, by Country, 2024 – 2033 (USD Million)
- 9.23.1 The Middle-East and Africa Apheresis Equipment Market, 2024 – 2033 (USD Million)
- 9.24 The Middle-East and Africa Apheresis Equipment Market, by Product Type, 2024 – 2033
- 9.24.1 The Middle-East and Africa Apheresis Equipment Market, by Product Type, 2024 – 2033 (USD Million)
- 9.25 The Middle-East and Africa Apheresis Equipment Market, by Technology, 2024 – 2033
- 9.25.1 The Middle-East and Africa Apheresis Equipment Market, by Technology, 2024 – 2033 (USD Million)
- 9.26 The Middle-East and Africa Apheresis Equipment Market, by Application, 2024 – 2033
- 9.26.1 The Middle-East and Africa Apheresis Equipment Market, by Application, 2024 – 2033 (USD Million)
- 9.27 The Middle-East and Africa Apheresis Equipment Market, by End User, 2024 – 2033
- 9.27.1 The Middle-East and Africa Apheresis Equipment Market, by End User, 2024 – 2033 (USD Million)
- Chapter 10. Company Profiles
- 10.1 Terumo BCT Inc.
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Fresenius SE & Co. KGaA
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Haemonetics Corporation
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Asahi Kasei Medical Co. Ltd.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Baxter International Inc.
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Kaneka Corporation
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 B. Braun Melsungen AG
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Nikkiso Co. Ltd.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Medica S.p.A.
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Miltenyi Biotec
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Thermo Fisher Scientific Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Hemonetics Corporation
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Cerus Corporation
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 MacoPharma
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Gambro
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Others.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.1 Terumo BCT Inc.
List Of Figures
Figures No 1 to 32
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Terumo BCT Inc.
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Asahi Kasei Medical Co. Ltd.
- Baxter International Inc.
- Kaneka Corporation
- Braun Melsungen AG
- Nikkiso Co. Ltd.
- Medica S.p.A.
- Miltenyi Biotec
- Thermo Fisher Scientific Inc.
- Hemonetics Corporation
- Cerus Corporation
- MacoPharma
- Gambro
- Others
FAQs
The key factors driving the Market are Rising Prevalence of Chronic Diseases, Technological Advancements, Growing Demand for Blood Components, Expanding Applications in Medical Treatments, Emerging Markets Expansion, Personalized Medicine and Precision Therapies, Integration with Digital Health Technologies.
The “Renal Disease” had the largest share in the global market for Apheresis Equipment.
The “Plasmapheresis Equipment” category dominated the market in 2023.
The key players in the market are Terumo BCT Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., Baxter International Inc., Kaneka Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd., Medica S.p.A., Miltenyi Biotec, Thermo Fisher Scientific Inc., Hemonetics Corporation, Cerus Corporation, MacoPharma, Gambro, Others.
“North America” had the largest share in the Apheresis Equipment Market.
The global market is projected to grow at a CAGR of 12.2% during the forecast period, 2024-2033.
The Apheresis Equipment Market size was valued at USD 4,673.2 Million in 2024.